Wen Shi

Wen Shi

Auto-generated profile, based on publicly available information

Wen Shi

McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYun Soo Hong
Yun Soo Hong
SBStephanie L. Battle
Stephanie L. Battle
WSWen Shi
Wen Shi
DPDaniela Puiu
Daniela Puiu
VPVamsee Pillalamarri
Vamsee Pillalamarri
DADan E. Arking
Dan E. Arking
Mitochondria carry their own circular genome and disruption of the mitochondrial genome is associated with various aging-related diseases. Unlike the nuclear genome, mitochondrial DNA (mtDNA) can be present at 1000 s to 10,000 s copies in somatic cells and variants may exist in a state of heteroplasmy, where only a fraction of the DNA molecules harbors a particular variant. We quantify mtDNA heteroplasmy in 194,871 participants in the UK Biobank and find that heteroplasmy is associated with a 1.5-fold increased risk of all-cause mortality. Additionally, we functionally characterize mtDNA single nucleotide variants (SNVs) using a constraint-based score, mitochondrial local constraint score sum (MSS) and find it associated with all-cause mortality, and with the prevalence and incidence of cancer and cancer-related mortality, particularly leukemia. These results indicate that mitochondria may have a functional role in certain cancers, and mitochondrial heteroplasmic SNVs may serve as a prognostic marker for cancer, especially for leukemia.

22 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYun Soo Hong
Yun Soo Hong
SPSergiu Pasca
Sergiu Pasca
WSWen Shi
Wen Shi
DPDaniela Puiu
Daniela Puiu
NLNicole J. Lake
Nicole J. Lake
LGLukasz P. Gondek
Lukasz P. Gondek
Clonal hematopoiesis of indeterminate potential is the primary pathogenic risk factor for myeloid neoplasms, while heteroplasmy (mutations in a subset of cellular mitochondrial DNA) is another marker of clonal expansion associated with hematological malignancies. We explore how these two markers relate and influence myeloid neoplasms incidence, and their role in risk stratification. We find that heteroplasmy is more common in individuals with clonal hematopoiesis of indeterminate potential, particularly those with higher variant allele fractions, multiple mutations, or spliceosome machinery mutations. Individuals with both markers have a higher risk of myeloid neoplasms than those with either alone. Furthermore, heteroplasmic variants with higher predicted deleteriousness increase the risk of myeloid neoplasms. Incorporating heteroplasmy in an existing risk score model for individuals with clonal hematopoiesis of indeterminate potential significantly improves sensitivity and better identifies high-risk groups. This suggests heteroplasmy as a clonal expansion marker and potentially as a biomarker for myeloid neoplasms development.

9 October 2025 in Science
Verified
Journal Article
Closed access
HHHuihui Huang
Huihui Huang
YWYi Wang
Yi Wang
ZZZsuzsanna Kinga Zsengeller
Zsuzsanna Kinga Zsengeller
JGJoshua M. Gorham
Joshua M. Gorham
VVVamsidhara Vemireddy
Vamsidhara Vemireddy
SPSamir M. Parikh
Samir M. Parikh
Somatically acquired mitochondrial DNA (mtDNA) mutations accumulate with age, but the mechanisms and consequences of this accumulation are poorly understood. Here we show that transient injuries induce a burst of persistent mtDNA mutations that impair resilience to future injuries. mtDNA mutations suppressed energy-intensive nucleotide metabolism. Repletion of adenosine, but not other nucleotides, restored adenosine triphosphate generation, which required a nuclear-encoded purine biosynthetic enzyme, adenylate kinase 4 (AK4). Analysis of 369,912 UK Biobank participants revealed a graded association between mutation burden and chronic kidney disease severity as well as an independent increase in the risk of future acute kidney injury events ( P < 10 −7 ). Heteroplasmic mtDNA mutations may therefore reflect the cumulative effect of acute injuries to metabolically active cells, impairing major functions in a fashion amenable to nuclear-controlled purine biosynthesis.

26 September 2022 in Human Genetics and Genomics Advances
Verified
Journal Article
Open access
VPVamsee Pillalamarri
Vamsee Pillalamarri
WSWen Shi
Wen Shi
CSConrad Say
Conrad Say
SYStephanie Yang
Stephanie Yang
JLJohn Lane
John Lane
DADan E. Arking
Dan E. Arking
Inter-individual variation in the number of copies of the mitochondrial genome, called mitochondrial DNA copy number (mtDNA-CN), reflects mitochondrial function and has been associated with various aging-related diseases. We examined 415,422 exomes of self-reported White ancestry individuals from the UK Biobank and tested the impact of rare variants, at the level of single variants and through aggregate variant-set tests, on mtDNA-CN. A survey across nine variant sets tested enrichment of putatively causal variants and identified 14 genes at experiment-wide significance and three genes at marginal significance. These included associations at known mtDNA depletion syndrome genes (mtDNA helicase TWNK, p = 1.1 × 10−30; mitochondrial transcription factor TFAM, p = 4.3 × 10−15; mtDNA maintenance exonuclease MGME1, p = 2.0 × 10−6) and the V617F dominant gain-of-function mutation in the tyrosine kinase JAK2 (p = 2.7 × 10−17), associated with myeloproliferative disease. Novel genes included the ATP-dependent protease CLPX (p = 8.4 × 10−9), involved in mitochondrial proteome quality, and the mitochondrial adenylate kinase AK2 (p = 4.7 × 10−8), involved in hematopoiesis. The most significant association was a missense variant in SAMHD1 (p = 4.2 × 10−28), found on a rare, 1.2-Mb shared ancestral haplotype on chromosome 20. SAMHD1 encodes a cytoplasmic host restriction factor involved in viral defense response and the mitochondrial nucleotide salvage pathway, and is associated with Aicardi-Goutières syndrome 5, a childhood encephalopathy and chronic inflammatory response disorder. Rare variants were enriched in Mendelian mtDNA depletion syndrome loci, and these variants implicated core processes in mtDNA replication, nucleoid structure formation, and maintenance. These data indicate that strong-effect mutations from the nuclear genome contribute to the genetic architecture of mtDNA-CN.

18 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SPSergiu Pasca
Sergiu Pasca
YHYun Soo Hong
Yun Soo Hong
WSWen Shi
Wen Shi
DPDaniela Puiu
Daniela Puiu
NLNicole J. Lake
Nicole J. Lake
LGLukasz P. Gondek
Lukasz P. Gondek
Chronic lymphocytic leukemia (CLL) can arise from lymphoid clonal hematopoiesis of indeterminate potential (L-CHIP), but many individuals who develop CLL lack detectable L-CHIP prior to diagnosis. To identify additional predictors of CLL risk, we analyze mitochondrial heteroplasmy in 419,154 individuals from the UK Biobank (UKB). Heteroplasmy is associated with a 1.5-fold increased risk of developing CLL, and this risk rises to 4-fold when accounting for deleterious heteroplasmic variants. These findings are confirmed in an independent cohort, the All of Us Research Program (AoU). Notably, the associations remain significant even in the absence of L-CHIP, highlighting heteroplasmy’s potential utility as an independent biomarker. Moreover, heteroplasmy is enriched in individuals with high-risk L-CHIP genotypes and large clonal burden, suggesting a potential biological role in malignant transformation. Here, we show that mitochondrial heteroplasmy, especially functionally deleterious variants, identifies individuals at increased risk of CLL who would otherwise go undetected by L-CHIP-based assessments.

21 November 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
MEMeghana Eswarappa
Meghana Eswarappa
RKRonit Katz
Ronit Katz
DADan E. Arking
Dan E. Arking
WSWen Shi
Wen Shi
CNCharles Newcomb
Charles Newcomb
VJVasantha Jotwani
Vasantha Jotwani
Key Points: In older adults, a higher burden of mitochondrial DNA heteroplasmy was associated with a higher risk of kidney function decline. In older adults, higher mitochondrial DNA copy number was associated with a lower risk of kidney function decline. Background: Blood-based measures of mitochondrial DNA (mtDNA), including lower copy number and inherited mutations, have been associated with higher incidence of CKD. However, the effect of mtDNA heteroplasmy, the age-associated accumulation of somatic mutations, is not well elucidated. We evaluated associations of mtDNA heteroplasmy and copy number (mtDNA-CN) with risk of kidney function decline. Methods: We conducted a case-cohort study among community-living participants of the Health, Aging, and Body Composition study. A random subcohort of 502 participants was selected at baseline. One hundred and fifty-seven cases with a ≥40% eGFR decline to <60 ml/min per 1.73 m 2 over 10 years of follow-up were identified, including 30 cases from the subcohort. Additional analyses evaluated ≥30% eGFR decline, present in 207 participants, including 80 within the subcohort. MtDNA heteroplasmy and mtDNA-CN were quantified from peripheral blood buffy coat specimens at baseline. A modified mitochondrial local constraint score sum (mMSS) was used to capture predicted deleterious consequences of mtDNA mutations. Modified Cox regression evaluated associations of each mtDNA exposure variable with the kidney outcomes. Results: Among participants in the random subcohort, the mean age was 74±3, 49% were female, and the mean baseline eGFR was 73±18 ml/min per 1.73 m 2 . In analyses adjusted for CKD risk factors, higher mMSS was associated with a higher risk of ≥40% eGFR decline to 0.5 versus 0). Higher mtDNA-CN was associated with a lower risk of ≥30% eGFR decline (HR, 0.79 [95% CI, 0.63 to 0.98] per SD higher; HR 0.55 [95% CI, 0.32 to 0.95] for highest versus lowest tertile) in adjusted analyses. Conclusions: In older community-dwelling adults, higher mtDNA heteroplasmy was associated with a higher risk of kidney function decline, while higher mtDNA-CN was associated with a lower risk of kidney function decline. These findings expand the measures of mitochondrial health that may provide insight into kidney disease progression and warrant exploration in higher-risk populations.